TY - JOUR
T1 - Micro-sample analysis of capsaicin by liquid chromatography-tandem mass spectrometry assay and application to oral absorption study
AU - Choi, Y.
AU - Shin, B.
AU - Kim, M.
AU - Shin, S.
AU - Choo, H.
AU - Kim, T.
AU - Jang, H.
AU - Yoo, S.
PY - 2013/6/1
Y1 - 2013/6/1
N2 - Capsaicin has been reported to exhibit an inhibitory effect on the P-glycoprotein (P-gp) function in vitro. To investigate its concentration- dependent effect in vivo, a sensitive assay that can characterize the absorption and disposition of capsaicin needs to be developed. This study reports the development of a sensitive LC-MS/MS assay for the determination of capsaicin in mouse plasma. The sample pretreatment involved a one-step extraction of 20 μL plasma with t-butyl methyl ether. Separations were achieved on a C18 column and the detection was performed on an LC-ESI-MS/MS by multiple reaction monitoring. The assay was linear over a wide concentration range from 0.325 to 650 ng mL-1 (r > 0.999), with a LLOQ of 0.325 ng mL-1. The developed method was applied to i.v. (dose 0.325 and 0.65 mg kg) and oral absorption (dose 40 mg kg) studies in mice. After i.v. injection, the t 1/2,λz, Vz and CLs ranged from 0.13-0.16 h, 127.6-141.8 mL, and 547.3-775.4 mL/h, respectively. After oral administration, a secondary peak was observed and the terminal half-life was prolonged (1.51 h). Capsaicin was poorly absorbed, with the absolute oral bioavailability (F) ranging from 1.02% to 1.56%. The developed assay may be useful in studies where sample volumes are limited.
AB - Capsaicin has been reported to exhibit an inhibitory effect on the P-glycoprotein (P-gp) function in vitro. To investigate its concentration- dependent effect in vivo, a sensitive assay that can characterize the absorption and disposition of capsaicin needs to be developed. This study reports the development of a sensitive LC-MS/MS assay for the determination of capsaicin in mouse plasma. The sample pretreatment involved a one-step extraction of 20 μL plasma with t-butyl methyl ether. Separations were achieved on a C18 column and the detection was performed on an LC-ESI-MS/MS by multiple reaction monitoring. The assay was linear over a wide concentration range from 0.325 to 650 ng mL-1 (r > 0.999), with a LLOQ of 0.325 ng mL-1. The developed method was applied to i.v. (dose 0.325 and 0.65 mg kg) and oral absorption (dose 40 mg kg) studies in mice. After i.v. injection, the t 1/2,λz, Vz and CLs ranged from 0.13-0.16 h, 127.6-141.8 mL, and 547.3-775.4 mL/h, respectively. After oral administration, a secondary peak was observed and the terminal half-life was prolonged (1.51 h). Capsaicin was poorly absorbed, with the absolute oral bioavailability (F) ranging from 1.02% to 1.56%. The developed assay may be useful in studies where sample volumes are limited.
KW - bioavailability
KW - capsaicin
KW - LC-MS/MS
KW - pharmacokinetics
UR - https://www.scopus.com/pages/publications/84878889592
U2 - 10.1556/AChrom.25.2013.2.11
DO - 10.1556/AChrom.25.2013.2.11
M3 - Article
AN - SCOPUS:84878889592
SN - 1233-2356
VL - 25
SP - 363
EP - 376
JO - Acta Chromatographica
JF - Acta Chromatographica
IS - 2
ER -